欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY J ENZYM INHIB MED CH (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.5
53人评分
我要评分
声誉 8.2 影响力 6.6 速度 9.7 | |||||||||||||||||||||||||||||||
期刊ISSN | 1475-6366 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||||||||||||
E-ISSN | 1475-6374 | |||||||||||||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 5.4 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:5.361 | |||||||||||||||||||||||||||||||
2024-2025自引率 | 1.90%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.9 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.36 | |||||||||||||||||||||||||||||||
h-index | 61 | |||||||||||||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://www.tandfonline.com/loi/ienz20 | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://mc.manuscriptcentral.com/genz | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY的语言要求,还能让JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes LetPub与Taylor & Francis签署APC支持服务战略合作协议,选择APC支持服务可享受:多样化支付选项,国税发票,加速发表,京东购物卡福利。了解详情>>> | |||||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( EUR2520; USD2630; GBP2100; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:enzymology、cell biology、chemical biology、microbiology、physiology、pharmacology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN | |||||||||||||||||||||||||||||||
出版商 | Informa Healthcare | |||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-生化与分子生物学 | |||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||||||||||||
出版年份 | 2002 | |||||||||||||||||||||||||||||||
年文章数 | 94点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 97.98% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 95.74% | |||||||||||||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-6366%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 偏慢,4-8周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( EUR2520; USD2630; GBP2100; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Identification of a novel and high affinity MIF inhibitor via structure-based pharmacophore modelling, molecular docking, molecular dynamics simulations, and biological evaluation Author: Zhu, Shang; Yang, Shudan; Chen, Yao; Niu, Miao-Miao; Wang, Jun; Li, Jindong; Pu, Xuehua Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2501378 PubMed DOI |
2. | Identification of potent inhibitors of potential VEGFR2: a graph neural network-based virtual screening and in vitro study Author: Hou, Shengzhen; Diao, Shuning; He, Yuxiang; Li, Taiying; Meng, Wenhui; Zhang, Jinping Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2518192 PubMed DOI |
3. | 2,5-Dihydroxyphenylethanone: an anti-melanogenic bioactive compound isolated from Ganoderma cochlear Author: Ning, Meng; Liu, Xiao-Cui; He, Min; Peng, Xing-Rong; Qiu, Ming-Hua Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2495364 PubMed DOI |
4. | Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer Author: Miao, Yingxiang; Yang, Shudan; Zhang, Fang; Li, Jindong; Zhang, Yan Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2488127 PubMed DOI |
5. | Liquidambaric acid as a non-competitive α-glucosidase inhibitor: multi-level evidence from enzyme kinetics, molecular docking, molecular dynamics simulations, and a Drosophila hyperglycaemic model Author: Jia, Liwei; Liu, Yan; Fu, Bo; Tian, Yuan; Meng, Xin Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2497486 PubMed DOI |
6. | Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity Author: Zhang, Da-Wei; Xu, Xiao-Shuang; Xie, Liangxu; Xu, Lei; Fu, Zhiguo; Li, Yimin; Xu, Xiaojun Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2501743 PubMed DOI |
7. | Activity guided discovery of dual inhibitors of α-glucosidase and β-glucuronidase from the leaves of Millettia pachycarpa Benth Author: He, Yanxi; Xu, Huanran; Tan, Shaoqian; Long, Jing; Lei, Hui; Xiao, Ling; Qi, Xiaoyi; Deng, Mingming; Xiong, Xia; You, Jingcan; Zhu, Liangliang; Lue, Muhan; Liang, Sicheng Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2501041 PubMed DOI |
8. | Design, synthesis and biological evaluation of novel urolithin derivatives targeting liver cancer cells Author: Tian, Mi; Zhao, Lirong; Lan, Yu; Li, Chen; Ling, Yipeng; Zhou, Benhong Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2490707 PubMed DOI |
9. | 27-Hydroxycholesterol in cancer development and drug resistance Author: Hou, Yaxin; Fu, Zhiguang; Wang, Chenhui; Kucharzewska, Paulina; Guo, Yuan; Zhang, Sihe Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2507670 PubMed DOI |
10. | Identification of broad-spectrum Mpro inhibitors: a focus on high-risk coronaviruses and conserved interactions Author: Liu, Man; Zhao, Li; Huang, Xupeng; Tang, Zhenhao; Zhong, Yihang; Yan, Mengrong; Liu, Shun; Wang, Shunjing; Sun, Zeyun; Rao, Zixuan; Yu, Linyi; Fang, Yuying; Zhang, Wei; Zhang, Hongbo; Peng, Wei Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2025; Vol. 40, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2503961 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室